Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.

Clinical lymphoma, myeloma & leukemia - 1 Apr 2021

Davila-Gonzalez Daniel, Barrios-Ruiz Alanna, Fountain Eric, Cheng Lee, Masarova Lucia, Verstovsek Srdan, Rojas-Hernandez Cristhiam M

Abstract excerpt

INTRODUCTION: Considering the evolving diagnostic criteria of polycythemia vera (PV), we analyzed the utility of serum erythropoietin (EPO) as a predictive marker for differentiating polycythemia vera (PV) from other etiologies of erythrocytosis. PATIENTS AND METHODS: We conducted a retrospective study after a review of electronical medical records from January 2005 to December 2016 with diagnosis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Erythropoietin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Janus Kinase 2

Share to Polycythemia

Share to Polycythemia Vera

Share to Predictive Value of Tests

Share to ROC Curve

Source

Identifiers

PMID: 33349602
DOI: 10.1016/j.clml.2020.11.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.PMID 33349602Read ↗

Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients.Semantic proximity Read ↗

Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis: A retrospective case seriesSemantic proximity Read ↗

Evaluation of Hemoglobin and Serum Erythropoietin Levels in Patients with Polycythemia Vera and Secondary polycythemiaSemantic proximity Read ↗

Erythropoietin levels in differentiating primary and secondary erythrocytosis, and correlation with JAK2 positivity: a retrospective chart reviewSemantic proximity Read ↗

The complete evaluation of erythrocytosis: congenital and acquired.Semantic proximity Read ↗

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.Semantic proximity Read ↗

Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia veraSemantic proximity Read ↗

The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.Semantic proximity Read ↗

JAK2 wild-type erythrocytosis: concept, differential diagnosis, diagnostic steps, and treatment approaches.Semantic proximity Read ↗

Low-hemoglobin Polycythemia Vera: Diagnostic Criteria and Clinico-pathological CharacterizationSemantic proximity Read ↗

Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.Semantic proximity Read ↗

Low neutrophil-to-lymphocyte ratio identifies secondary polycythemia in patients with erythrocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.